Application
Dot blot analysis of anti-Phospho-TNFRSF8-pY479 Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Product Name | Phospho-TNFRSF8 -Y479 Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | TNFRSF8; CD30; D1S166E; Tumor necrosis factor receptor superfamily member 8; CD30L receptor; Ki-1 antigen; Lymphocyte activation antigen CD30; CD_antigen=CD30; Flags: Precursor |
| Modification | p-Y479 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | DB |
| DB:1:500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | CD30 D1S166E |
|---|---|
| Alternative Names | TNFRSF8 CD30 D1S166E Tumor necrosis factor receptor superfamily member 8 CD30L receptor Ki-1 antigen Lymphocyte activation antigen CD30 CD_antigen=CD30 Flags: Precursor |
| Molecular Weight(MW) | 63747 Da |
| Function | Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF- kappa-B |
| Tissue Specificity | This Phospho-TNFRSF8-Y479 antibody is generated from rabbits immunized with a KLH conjugated synthetic phosphopeptide between 465~495 amino acids surrounding Y479 of human TNFRSF8. |
| Cellular Localization | Isoform Long: Cell membrane; Single-pass type I membrane protein |
| Entrez Gene | 943 |
|---|
Application
Dot blot analysis of anti-Phospho-TNFRSF8-pY479 Phospho-specific Pab on nitrocellulose membrane. 50ng of Phospho-peptide or Non Phospho-peptide per dot were adsorbed. Antibody working concentrations are 0.5ug per ml.| Application Notes | DB:1:500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by two-step phosphospecific peptide affinity purification. |
